Literature DB >> 14633925

Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin.

Hubert A Carchon1, Roland Chevigné, Jean-Bernard Falmagne, Jaak Jaeken.   

Abstract

BACKGROUND: Congenital disorders of glycosylation (CDG) are usually diagnosed by isoelectric focusing (IEF) of serum transferrin (Tf). The aim of this study was to evaluate capillary zone electrophoresis (CZE) as a diagnostic alternative to IEF.
METHODS: We performed 792 CZE analyses of Tf, using the CEofix(TM)-CDT (carbohydrate-deficient transferrin) assay. Peak identification was based on relative migration times (RMTs) to reduce migration variability.
RESULTS: Tf profiles comprised three main groups (A-C). Groups A and B were characterized by one or two dominant tetrasialo-Tf peaks, whereas group C showed a widely variable Tf isoform composition. Group A was composed of four subgroups: a major group with a typical Tf profile (considered as reference group), two minor groups with decreased or moderately increased trisialo-Tf isoform, and a group showing the presence of unknown compounds with RMTs similar to mono- and disialo-Tf. However, these compounds were absent on IEF. Group C contained all profiles from patients with confirmed as well as putative CDG. From the reference group, 99% confidence intervals were calculated for the RMTs of the Tf isoforms, and percentiles representing the Tf isoform distributions were defined.
CONCLUSIONS: All patients with abnormal IEF results and confirmed CDG were identified by CZE; thus, this method can be used as a diagnostic alternative to IEF in a manner suitable for automation. Because whole serum is analyzed, it should be kept in mind that CZE profiles can show substances other than Tf.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633925     DOI: 10.1373/clinchem.2003.021568

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  22 in total

1.  Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).

Authors:  M Casado; M M O'Callaghan; R Montero; C Pérez-Cerda; B Pérez; P Briones; E Quintana; J Muchart; A Aracil; M Pineda; R Artuch
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies.

Authors:  Duygu Selcen; Xin-Ming Shen; Joan Brengman; Ying Li; Anthony A Stans; Eric Wieben; Andrew G Engel
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

3.  Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype.

Authors:  Eline Blommaert; Romain Péanne; Natalia A Cherepanova; Daisy Rymen; Frederik Staels; Jaak Jaeken; Valérie Race; Liesbeth Keldermans; Erika Souche; Anniek Corveleyn; Rebecca Sparkes; Kaustuv Bhattacharya; Christine Devalck; Rik Schrijvers; François Foulquier; Reid Gilmore; Gert Matthijs
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

5.  Employment of single-strand conformation polymorphism analysis in screening for α-1,3 glucosyltransferase gene mutation A333V in Croatian population.

Authors:  Sandra Supraha Goreta; Sanja Dabelic; Jerka Dumic
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

6.  Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congenital disorders of glycosylation.

Authors:  Mihika B Dave; Alpa J Dherai; Vrajesh P Udani; Anaita U Hegde; Neelu A Desai; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

7.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

8.  Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.

Authors:  Bobby G Ng; Carla G Asteggiano; Martin Kircher; Kati J Buckingham; Kimiyo Raymond; Deborah A Nickerson; Jay Shendure; Michael J Bamshad; Matthias Ensslen; Hudson H Freeze
Journal:  Am J Med Genet A       Date:  2017-08-29       Impact factor: 2.802

9.  Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.

Authors:  B Shanti; M Silink; K Bhattacharya; N J Howard; K Carpenter; M Fietz; P Clayton; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2009-04-27       Impact factor: 4.982

Review 10.  The congenital disorders of glycosylation: a multifaceted group of syndromes.

Authors:  Erik A Eklund; Hudson H Freeze
Journal:  NeuroRx       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.